The MBMD test was normed on over 700 medical patients with a variety of medical conditions. The norm group included patients with the following conditions: heart problems, cancer, diabetes, gynecological problems, chronic pain, accident/injury, back pain, headaches, neurological problems, gastrointestinal problems, organ transplants, and HIV/AIDS. Approximately 52% of the sample were female, 60% were Caucasian, 48% were married, and 89% had at least a high school diploma.
Recently, bariatric-specific norms were developed for the MBMD test. Using data from 711 prescreened bariatric surgery patients collected across six geographically diverse settings, a bariatric reporting option was developed to represent this unique medical population. Approximately 82% of this sample were female, 65% were Caucasian, 54% were married, and 89% had at least a high school diploma.
Pain patient-specific norms were released for the MBMD in 2010. All 1,200 pain patients, pulled from diverse settings across the U.S., were given the MBMD; included were patients with a variety of ailments and injuries (back, joints, neck, head) and were being evaluated for treatment. This data helped to develop two reports tailored to help assess individuals in two primary pain patient settings, Presurgical and Nonsurgical. Approximately 54% of this sample were female, 69% were Caucasian, 62% were married, and 46% had at least a high school diploma.
Among several differences between norm groups, bariatric and pain patients tend to be more concerned about illness, more prohibited from doing things, and in more pain than the general medical population. Differences such as these indicate that the average bariatric or pain patient is not only physically different from the general medical population but psychologically different as well, justifying the effort to bring a more specific norm groups to MBMD users.
Internal consistency and test-retest analyses were conducted to estimate the reliability of the MBMD scales. Using the entire sample, the following internal consistency coefficients were obtained: Psychiatric Indications (rTT=.76 to .89), Coping Styles (rTT=.54 to .85), Stress Moderators (rTT=.85 to .89), Treatment Prognostics (rTTTT=.47 to .80), and Management Guides (rTT=.77 to .79). The median internal consistency coefficient for all scales is rTT=.79. Using a smaller sample (N=41), test-retest reliability estimates were also obtained: Psychiatric Indications (rTT=.79 to .88), Coping Styles (rTT=.71 to .90), Stress Moderators (rTT=.78 to .92), Treatment Prognostics (rTT=.72 to .88), and Management Guides (rTT=.78 to .81). The median test-retest coefficient for all scales is rTT=.83.
Internal consistency and test-retest analyses were also conducted for the bariatric patient sample, resulting in the following reliability estimates: Psychiatric Indicators (rTT = .70 to .85), Coping Styles (rTT = .56 to .80), Stress Moderators (rTT = .77 to .89), Treatment Prognostics (rTT = .22 to .71), and Management Guides (rTT = .64 to .69). The median internal consistency coefficient for all scales is rTT = .70.
Several approaches were used to validate the scales included on the MBMD. First, an item-sorting procedure was used that required several medical professionals to identify which scale(s) each item appeared to be logically associated with. Only items that were sorted correctly by the majority of the raters were retained on the test for further analysis.
Second, after the MBMD scales had been refined based on internal consistency considerations, scale scores were correlated with a variety of other measures that assessed similar content domains. For example, the MBMD Depression scale correlated at .87 with the Beck Depression Inventory and .58 with the Brief Symptom Inventory Depression scale.
Third, medical professionals who were familiar with approximately 100 patients rated each patient on a number of attitudes and behaviors that are important to treatment outcomes (e.g., compliance, medication problems, utilization problems). A number of significant relationships were found between the MBMD scales and the medical staff ratings. For example, the Pain Sensitivity scale correlated .62 with a rating of Pain Experiences. The Adjustment Difficulties scale correlated .61 with a rating of Utilization Problems.
Because the MBMD test is normed on medical patients, it can be used with patients who are undergoing a variety of medical care, rehabilitation, or surgical treatment regimens. The MBMD can help identify patients with psychiatric problems and recommend interventions. It can also help pinpoint personal and social assets that can help the patient adjust to physical limitations or lifestyle changes.
It is not appropriate to use the MBMD test with adolescents. The age range for the MBMD test is 18 to 89 years old.